Scientists are racing to develop a vaccine for the coronavirus, with a team in the UK saying that clinical trials could start by the end of the week.
But what needs to be done before a vaccine can be used on the general population?
READ MORE: Coronavirus in Scotland: Cancer fear as people stay away from GPs
What is a vaccine?
Vaccines harmlessly expose viruses or bacteria to the body’s immune system, causing it to recognise them as dangerous and learn how to resist them.
This means that if the body comes across the infection, it knows how to defend itself.
What are the first tests that vaccines go through?
Once scientists have developed a new vaccine, it has to go through laboratory testing and development, which involves “in vitro” testing – test tube experiments – and “in vivo” testing, which is usually on animals, often mice.
After researchers put the vaccine through rigorous tests and can demonstrate that it works in animals, they can move on to an initial trial in a small number of humans.
What tests are done on humans?
An initial phase one trial is usually carried out on a small group of up to 100 people to make sure the vaccine has no major safety concerns and to allow scientists to work out an effective dose in humans.
The phase two study is carried out on a larger group of around several hundred people to check if the vaccine works consistently and generates an immune response, as well as to look for possible side effects.
Then a much larger phase three study – potentially on several thousand people – can be carried out which allows scientists to gather statistically significant data on a vaccine’s safety and efficacy.
This means looking at whether the vaccine generates a level of immunity that would prevent disease and provide evidence that the vaccine can actually reduce the number of cases. It also gives a better chance of identifying rarer side effects not seen in the phase two study.
How is a new vaccine licensed?
If all goes well, the next stage involves an expert review of all trial data by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA).
The regulators check that the trials show that the product meets the necessary efficacy and safety levels. They also make sure that, for most people, its advantages far outweigh the disadvantages.
After the expert review, the regulator can grant a licence for the vaccine which confirms the medical condition the medicine should be used for and the recommended dosage.
How long does it take to be granted a licence?
There are a number of different licences, depending on where the producer wants to market its vaccine.
If a vaccine already has a national licence for a country in the EU, it can take up to 90 days to extend it to other member states, but new licences can take up to 210 days excluding any time taken to provide any further information or data, the MHRA’s website said.
But some medicines can be fast-tracked if there is “compelling” evidence the product will be a major breakthrough in the treatment of certain conditions.
These include chronic, debilitating diseases, severe or life-threatening diseases, and the emergence of a new disease entity which has severe or life-threatening effects and for which currently available treatments are ineffective or inadequate.
READ MORE: Coronavirus in Scotland: No fans at football matches 'any time soon'
How are vaccines monitored after they are approved?
Post-marketing analysis is conducted to monitor the effects of the vaccine after it has been used in the population.
The vaccine is also monitored in the UK through the MHRA’s Yellow Card scheme, with reports of suspected side effects sent in by drug companies, health professionals, and patients themselves.
What happens if new side effects appear after a vaccine is in wider circulation?
If a previously unidentified reaction emerges, or the frequency of reactions is not in line with what is expected, then the MHRA can investigate.
After an investigation, the MHRA can lead to changes in the licence or take action such as changing the warnings in the product information.
It can also change the legal status of a medicine from over-the-counter to prescription-only or in rare circumstances remove the medicine from the market.
News from trusted and credible sources is essential at all times, but especially now as the coronavirus pandemic impacts on all aspects of our lives. To make sure you stay informed during this difficult time our coverage of the crisis is free.
However, producing The Herald's unrivalled analysis, insight and opinion on a daily basis still costs money and, as our traditional revenue streams collapse, we need your support to sustain our quality journalism.
To help us get through this, we’re asking readers to take a digital subscription to The Herald. You can sign up now for just £2 for two months.
If you choose to sign up, we’ll offer a faster loading, advert-light experience – and deliver a digital version of the print product to your device every day. Click here to help The Herald.
Thank you, and stay safe.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here